|
|
 |
| |
 |
Press Releases - 2010 |
 |
|
| |
To view our documents, you must use PDF software.
All documents are compatible
with Adobe® v6.0 and higher. |
|
|
AUGUST 09, 2010
CPEX PHARMACEUTICALS REPORTS SECOND-QUARTER 2010 FINANCIAL RESULTS
MAY 26, 2010
CPEX PHARMACEUTICALS SHAREHOLDERS ELECT ROBERT FORRESTER TO BOARD OF DIRECTORS
MAY 06, 2010
CPEX PHARMACEUTICALS BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS SHAREHOLDERS REJECT TENDER OFFER ANNOUNCED BY RICHARD ROFÉ
MAY 05, 2010
CPEX PHARMACEUTICALS REPORTS FIRST-QUARTER 2010 FINANCIAL RESULTS
APRIL 30, 2010
CPEX PHARMACEUTICALS APPOINTS ROBERT FORRESTER TO BOARD OF DIRECTORS
APRIL 23, 2010
CPEX PHARMACEUTICALS ADVISES SHAREHOLDERS TO TAKE NO ACTION
AT THIS TIME IN RESPONSE TO ARCADIA UNSOLICITED TENDER OFFER
APRIL 12, 2010
CPEX PHARMACEUTICALS ISSUES OPEN LETTER TO SHAREHOLDERS
APRIL 01, 2010
CPEX PHARMACEUTICALS’ PARTNER ANNOUNCES
DEVELOPMENT AND COMMERCIALIZATION AGREEMENT WITH ALLERGAN FOR NOCTURIA PRODUCT CANDIDATE
MARCH 18, 2010
CPEX PHARMACEUTICALS FILES PRELIMINARY
PROXY MATERIALS AND NOMINATES HIGHLY QUALIFIED INDEPENDENT BOARD CANDIDATE FOR ELECTION AT 2010 ANNUAL MEETING
MARCH 17, 2010
CPEX PHARMACEUTICALS ANNOUNCES PRELIMINARY
RESULTS FROM ITS PHASE 2A CLINICAL TRIAL OF NASULIN™
MARCH 03, 2010
CPEX PHARMACEUTICALS REPORTS 2009
FOURTH-QUARTER AND YEAR-END FINANCIAL RESULTS
FEBRUARY 18, 2010
CPEX PHARMACEUTICALS ANNOUNCES
ARCADIA OPPORTUNITY MASTER FUND WITHDRAWS PREVIOUSLY STATED INTENTION TO SUBMIT SHAREHOLDER PROPOSALS AND NOMINATE DIRECTOR SLATE
AT 2010 ANNUAL MEETINGARCADIA RETAINS INTENT TO NOMINATE ONE DIRECTOR
FEBRUARY 01, 2010
CPEX PHARMACEUTICALS ANNOUNCES
APPOINTMENT OF NEW CHIEF SCIENTIFIC OFFICER
JANUARY 08, 2010
CPEX PHARMACEUTICALS REPORTS ON
SEC FILING BY ARCADIA CAPITAL ADVISORS
If you are interested in receiving an investor packet, please call us at 603.658.6100.
|
| |
|
|
|
